Showing results (611-620 of 10,439) with videos related to

Sort By:
Pageof 1,044
AIDS (London, England)|February 25, 2022
Unmet needs for HIV ancillary care services by healthcare coverage and Ryan White HIV/AIDS program assistanceSharoda Dasgupta, Stacy M Crim, Lindsey Dawson, et al.
AIDS (London, England)|March 24, 2022
Coronavirus disease 2019 hospitalization outcomes in persons with and without HIV in SpainJulián Olalla-Sierra, María Dolores Martín-Escalante, Javier García-Alegría, et al.
AIDS (London, England)|June 13, 2018
Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in BotswanaKaelo K Seatla, Ava Avalos, Sikhulile Moyo, et al.
AIDS (London, England)|June 13, 2018
Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxisMaria Pyra, Peter L Anderson, Craig W Hendrix, et al.
AIDS (London, England)|June 13, 2018
Preferences for linkage to HIV care services following a reactive self-test: discrete choice experiments in Malawi and ZambiaMarc d'Elbée, Pitchaya P Indravudh, Lawrence Mwenge, et al.
AIDS (London, England)|December 22, 1999
Filgrastim treatment of HIV-infected patients improves neutrophil functionD L Pitrak
AIDS (London, England)|December 22, 1999
Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytesB Kohleisen, E Shumay, G Sutter, et al.
AIDS (London, England)|December 22, 1999
Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infectionA M Dyrhol-Riise, P Voltersvik, J Olofsson, et al.
AIDS (London, England)|December 22, 1999
A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 studyF García, J Romeu, I Grau, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
Pageof 1,044